TSX/MDP (TSX/MDP)

Toronto Stock Exchange: TSX/MDP · CAD

CA$5.04

+0.09 (+1.8%)· Recorded snapshot

Market cap	158.4M
Revenue (ttm)	146.7M
Net income (ttm)	-3.4M
EPS (ttm)	-CA$0.10
Shares out	31.4M
P/E (forward)	12.8x
Volume	54,710
Beta	1.73

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 146.7M
Net income (ttm): -3.4M
EPS (ttm): -CA$0.10
P/E (forward): 12.8x
Market cap: 158.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E12.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-4.7

P25 n/aP50 n/aP75 n/a

ROIC10.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/MDP indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-04
Employees	90
Employees change	-1
Employees growth	-1.1%
Enterprise value	CAD 188.1M
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA58410Q2036
Last earnings date	2026-06-25
Last refreshed	2026-10-29
Last stock split date	2018-12-19
Last stock split type	Reverse
Market cap	CAD 158.4M
Next earnings date	2026-11-04
Price	CAD 5.04
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	tsx/MDP
Website	https://www.medexus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	45.01x
Earnings yield	-2.07%
EV/EBIT	18.38x
EV/EBITDA	7.76x
EV/FCF	9.2x
EV/Sales	1.26x
FCF / EV yield	10.87%
FCF yield	12.94%
Forward P/E	12.83x
Industry forward P/E	34.4x
P/(FCF - SBC) ratio	7.83x
P/(OCF - SBC) ratio	7.8x
P/B ratio	2.28x
P/FCF ratio	7.73x
P/OCF ratio	7.7x
P/S ratio	1.06x
Price/EBITDA ratio	6.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.87%
EBITDA margin	16.11%
FCF margin	13.93%
Gross margin	63.86%
Operating margin	6.87%
Pretax margin	-2.31%
Profit margin	-2.29%
Profit per employee	CAD -37,333
Profitable quarters	1
Revenue per employee	CAD 1.6M
ROA	3%
ROA (5Y)	2.01%
ROCE	7.32%
ROE	-4.68%
ROE (5Y)	-2.02%
ROIC	10.62%
ROIC (5Y)	-3.74%
SBC / revenue	0.18%
Tax / revenue	-0.02%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	6.85%
EPS growth quarters	1
EPS growth years	0
FCF growth	-27.24%
FCF growth 3Y	28.3%
Gross profit growth	3.97%
Gross profit growth (Q)	13.11%
Gross profit growth 3Y	-1.96%
Gross profit growth 5Y	8.62%
Net income growth (Q)	5.43%
Net income growth quarters	1
Net income growth years	0
OCF growth	-28%
OCF growth 10Y	27.62%
OCF growth 3Y	27.99%
Operating income growth	-15.9%
Operating income growth (Q)	148.71%
Operating income growth 3Y	-18.82%
Revenue growth	-2.24%
Revenue growth (Q)	16.13%
Revenue growth (QoQ)	15.95%
Revenue growth 10Y	41.95%
Revenue growth 3Y	-3.96%
Revenue growth 5Y	6.07%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -72,425
Depreciation and amortization	CAD 13.4M
EBIT	CAD 10.1M
EBITDA	CAD 23.6M
EPS	CAD -0.10
FCF per share	CAD 0.64
Financing cash flow	CAD -859,161
Free cash flow	CAD 20.1M
Free cash flow minus SBC	CAD 19.9M
Gross profit	CAD 93.7M
Income taxes	CAD -31,242
Investing cash flow	CAD -24.9M
Net borrowing	CAD 5.2M
Net cash flow	CAD -5.7M
Net income	CAD -3.4M
Operating cash flow minus SBC	CAD 19.9M
Operating income	CAD 10.1M
Revenue	CAD 146.7M
Stock-based compensation	CAD 266,979

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.85
Book value per share	CAD 2.17
Debt / EBITDA	1.56
Debt / equity	0.55
Debt / FCF	1.85
Goodwill	CAD 14.1M
Interest coverage	1.41
Long-term assets	CAD 119.4M
Long-term liabilities	CAD 70.4M
Net cash (debt)	CAD -29.7M
Net cash / market cap	-19.09%
Net debt / EBITDA	1.26
Net debt / equity	0.44
Net debt / FCF	1.47
Piotroski F-Score	5
Property, plant and equipment	CAD 520,603
Shareholders' equity	CAD 68.3M
Tangible book value	CAD -33.9M
Tangible book value per share	CAD -1.08
Total assets	CAD 201.8M
Total cash	CAD 7.6M
Total debt	CAD 37.3M
Total liabilities	CAD 133.5M
WACC	14.04%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.7
Current assets	CAD 82.4M
Current liabilities	CAD 63.2M
Current ratio	1.3
Inventory turnover	1.14
Net working capital	CAD 15.3M
Quick ratio	0.41
Working capital	CAD 19.5M
Working capital turnover	-315.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-13.18%
Shareholder yield	-13.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	34.4%
10Y return CAGR	3%
10Y total return	34.4%
150-day SMA	CAD 4.54
1D price change	1.82%
1M price change	-1.56%
1M total return	-1.56%
1W price change	1.21%
1W total return	1.21%
1Y price change	79.36%
1Y return CAGR	79.43%
1Y total return	79.36%
20-day SMA	CAD 4.90
200-day SMA	CAD 4.14
3M price change	4.13%
3M total return	4.13%
3Y price change	147.06%
3Y return CAGR	35.18%
3Y total return	147.06%
50-day SMA	CAD 5.01
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 5.50
52-week high date	2026-08-12
52-week low	CAD 2.51
52-week low date	2025-11-20
5Y price change	54.6%
5Y return CAGR	9.11%
5Y total return	54.6%
6M price change	27.6%
6M total return	27.6%
All-time high	CAD 11.25
All-time high date	2014-01-02
All-time low	CAD 0.88
All-time low date	2022-09-27
Average true range (ATR)	CAD 0.15
Average volume	35.5K
Beta (1Y)	0.56
Beta (2Y)	1.2
Beta (5Y)	1.73
Change from 52-week high	-8.36%
Change from 52-week low	100.8%
Change from all-time high	-55.2%
Change from all-time low	472.73%
Change from open	4.13%
Day's gap	-2.22%
Dollar volume	CAD 275,738
High price	CAD 5.07
Low price	CAD 4.80
Monthly RSI	67.28
Open price	CAD 4.84
Position in 52-week range	88.89%
Previous close	CAD 4.95
Price vs 150-day SMA	10.96%
Price vs 20-day SMA	2.86%
Price vs 200-day SMA	21.62%
Price vs 50-day SMA	0.54%
Relative volume	1.54
RSI	55.28
Sharpe ratio	1.6
Sharpe ratio (3Y)	0.72
Sharpe ratio (5Y)	0.41
Sortino ratio	3.1
Sortino ratio (3Y)	1.19
Sortino ratio (5Y)	0.72
Volume	54.7K
Weekly RSI	62.56
YTD price change	73.2%
YTD total return	73.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28.8M
Shares change (QoQ)	-1.43%
Shares change (YoY)	13.18%
Shares held by insiders	8.28%
Shares held by institutions	3.33%
Shares outstanding	31.4M
Short % of float	0.62%
Short % of shares	0.56%

Deeper analysis on TSX/MDP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/MDP report

Is a complete TSX/MDP research report available?

No complete published report is available for tsx/MDP (TSX/MDP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/MDP (TSX/MDP)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/MDP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/MDP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/MDP

Frequently asked questions